Skip Navigation

European Heart Journal 2001 22(4):283-293; doi:10.1053/euhj.2000.2152
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Valenzuela Garcia, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Valenzuela Garcia, L. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review Article

Therapeutic options for the management ofpatients with cardiac syndrome X

J. C. Kaskif1 and L. F. Valenzuela Garcia

Coronary Artery Disease Research Unit, Department of Cardiological Sciences, St George's Hospital Medical School, London, U.K.

revised January 25, 2000; accepted January 27, 2000

Key Words: Syndrome X, chest pain and normal coronary arteriograms, angina

f1 Correspondence: Professor Juan Carlos Kaski, Coronary Artery Disease Research Unit; Cardiological Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, U.K.

References

  1. Kaski JC. Chest pain with normal coronary angiogram; pathogenesis, diagnosis and management. Kaski JC. Angina pectoris and normal coronary arteries: syndrome X. Boston: Kluwer Academic Publishers; 1999. p. 1–12
  2. Kaski JC, Elliott PM. Angina pectoris and normal coronary angiograms. Clinical presentation and hemodynamic characteristics. Am J Cardiol. 1995;76:35D–42D[CrossRef][Medline]
  3. Cannon RO, Epstein SE. ‘Microvascular angina’ as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338–1343[CrossRef][Web of Science][Medline]
  4. Rosano GM, Kaski JC, Arie S. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J. 1996;17:1175–1180[Abstract/Free Full Text]
  5. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: Clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol. 1995;:25–14
  6. Kemp HG, Vokonas PS, Cohn PF, Gorlin R. The anginal syndrome associated with normal coronary angiograms. Am J Med. 1973;54:735–742[CrossRef][Web of Science][Medline]
  7. Atienza Fernandez F, Brown S, Velasco J, Ridocci F, Kaski JC. Assessment of quality of life in patients with chest pain and normal coronary arteriograms (syndrome X) using a specific questionnaire. Clinc Cardiol. 1999;22:283–290
  8. Bugiardini R, Borghi A, Pozzati A, Ottani F, Morgnagni GL, Puddu P. Paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries. Am J Cardiol. 1993;72:343–347[CrossRef][Web of Science][Medline]
  9. Buffon A, Conti E, Finocchiaro ML. Paradoxical effect of intracoronary nitrates on coronary blood flow in patients with syndrome X (Abstr). Eur Heart J. 1997;18:169[Free Full Text]
  10. Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerin in identifying patients with syndrome X. Am Heart J. 1994;127:531–535[CrossRef][Web of Science][Medline]
  11. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation. 1994;90:2695–2700[Abstract/Free Full Text]
  12. Cannon R, Watson RM, Rosing DR, Epstein SE. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol. 1985;56:242–246[CrossRef][Web of Science][Medline]
  13. Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propanolol therapy in Syndrome X. Am J Cardiol. 1989;63:286–290[CrossRef][Web of Science][Medline]
  14. Montorsi P, Manfredi M, Loaldi A. Comparison of coronary vasomotor responses to nifedipine in Syndrome X and in Prinzmetal's angina pectoris. Am J Cardiol. 1989;63:1198–1202[CrossRef][Web of Science][Medline]
  15. Montorsi P, Cozzi S, Loaldi A. Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol. 1990;66:302–307[CrossRef][Web of Science][Medline]
  16. Sutch G, Oechslin E, Mayer I, Hess OM. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol. 1995;52:135–143[CrossRef][Web of Science][Medline]
  17. Cannon R, Brush JE, Schenke WH, Tracy CM, Epstein SE. Beneficial and detrimental effects of lidoflazine in microvascular angina. Am J Cardiol. 1990;66:37–41[CrossRef][Web of Science][Medline]
  18. Hongo M, Tanenaka H, Uchikawa S, Nakatsuka T, Watanabe N, Sekigushi A. Coronary microvascular response to intracoronary administration of nicorandil. Am J Cardiol. 1995;75:246–250[CrossRef][Web of Science][Medline]
  19. Yamabe H, Namura H, Yano T, Fujita H, Kim S, Iwahashi M. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary angiograms. Cardiovac Drugs Ther. 1995;9:755–761[CrossRef]
  20. Chen JW, Lee WL, Hsu NW. Effect of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Am J Cardiol. 1997;80:32–38[CrossRef][Web of Science][Medline]
  21. Nalbantgil S, Altintigbreve A, Yilmaz H, Nalbangtil I, Onder R. The effect of trimetazidine in the treatment of microvascular angina. Int J Angiol. 1999;8:40–43[Medline]
  22. Leonardo F, Fragasso G, Rosano GM, Pagnotta P, Chierchia SL. Effect of atenolol on QT interval and dispersion in patients with Syndrome X. Am J Cardiol. 1997;80:789–790[CrossRef][Web of Science][Medline]
  23. Fragasso G, Chierchia SL, Pizzetti G. Impaired left ventricular filling dynamics in patients with angina and angiografically normal coronary arteries:effect of B adrenergic blockade. Heart. 1997;77:32–39[Abstract/Free Full Text]
  24. Romeo F, Gaspardone A, Ciavolella M, Gioffre P, Reale A. Verapamil versus acebutolol for syndrome X. Am J Cardiol. 1988;62:312–313[CrossRef][Web of Science][Medline]
  25. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84:854–856[CrossRef][Web of Science][Medline]
  26. Galassi AR, Kaski JC, Pupita G, Vejar M, Crea F, Maseri A. Lack of evidence for alpha-adrenergic receptor mediated mechanisms in the genesis of ischemia in syndrome X. Am J Cardiol. 1989;64:264–269[CrossRef][Web of Science][Medline]
  27. Camici PG, Marracini P, Gistri R, Salvadori PA, Sorace O, L'abbate A. Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther. 1994;8:221–226[CrossRef][Web of Science][Medline]
  28. Botker HA, Sonne HS, Schmitz O, Nielsen TT. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression and insulin sensitivity in patients with Syndrome X. Am J Cardiol. 1998;82:1352–1356[CrossRef][Web of Science][Medline]
  29. Cannon RO, Quyyumi AA, Mincemoyer R. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 1994;330:1411–1417[Abstract/Free Full Text]
  30. Mancini GB, Henry GC, Macaya C. Angiotensin-converting enzyme inhibition with quinapril improves improve endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND study. Circulation. 1996;:94–65
  31. Griendling KK, Alexander RW. Oxidative Stress and Cardiovascular Disease. Circulation. 1997;96:3264–3265
  32. Iwatsubo H, Nagano M, Sakai T. Converting enzyme inhibitor improves forearm reactive hyperaemia in essential hypertension. Hypertension. 1997;29:286–290[Abstract/Free Full Text]
  33. Ganten D. Peptidergic control of cardiovascular function: the angiotensin paradigm. Eur Heart J. 1990;11:72–78
  34. Perondi R, Saino A, Tio RA. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 1992;85:2004–2013[Abstract/Free Full Text]
  35. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exerciseinduced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol. 1994;23:652–657[Abstract]
  36. Nalbantgil I, Onder R, Altinting A. Therapeutic benefits of cilazapril in patients with syndrome X. Cardiology. 1998;89:130–133[CrossRef][Web of Science][Medline]
  37. Ozcelik F, Altun A, Ozbay G. Antianginal and anti-ischemic effects of nisoldipine and ramipril in patients with syndrome X. Clin Cardiol. 1999;22:361–365[Web of Science][Medline]
  38. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499–506[Web of Science][Medline]
  39. Lagerquist B, Silven C, Waldenstrom A. Low threshold for adenosine induced chest pain in patients with angina pectoris and normal coronary angiogram. Br Heart J. 1992;68:282–283[Abstract/Free Full Text]
  40. Picano E, Pogliani M, Lattanzi F, L'Abbate A. Exercise capacity after acute aminophylline administration in angina pectoris. Am J Cardiol. 1989;63:14–16[CrossRef][Web of Science][Medline]
  41. Crea F, Pupita G, Galassi AR. Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanism of action. Am J Cardiol. 1989;64:1098–1102[CrossRef][Web of Science][Medline]
  42. Emdin M, Picano E, Lattanzi F, L'Abbatte A. Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol. 1989;14:1450–1453[Abstract]
  43. Yoshio H, Shimizu M, Kita Y. Effects of short term aminophylline administration on cardiac functional reserve in patients with syndrome X. J Am Coll Cardiol. 1995;25:1547–1551[Abstract]
  44. Elliott P, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC. Effects of oral aminophylline in patients with angina and normal coronary arteriograms. Heart. 1997;77:523–526[Abstract/Free Full Text]
  45. Chauhan A, Mullins PA, Thuraisinghan SI, Taylor G, Petch MC, Shofield PM. Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol. 1994;24:329–335[Abstract]
  46. Lanza GA, Gaspardone A, Pasceri V. Effects of bamiphylline on exercise testing in patients with syndrome X. G Ital Cardiol. 1997;27:50–54[Medline]
  47. Radice M, Giudici V, Pusineri E. Different effects of acute administration of aminophylline and nitroglycerin on exercise capacity in patients with syndrome X. Am J Cardiol. 1996;78:88–92[CrossRef][Web of Science][Medline]
  48. Magni G. The use of antidepressants in the treatment of chronic pain. Drugs. 1991;42:730–748[Web of Science][Medline]
  49. Cox I, Hann C, Kaski JC. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J. 1998;19:250–254[Abstract/Free Full Text]
  50. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–979[Free Full Text]
  51. Mannheimer C, Carlsson CA, Emmanuelson H. TENS in angina pectoris. Circulation. 1985;71:308–316[Abstract/Free Full Text]
  52. Chauhan A, Mullins PA, Thuraisingham SI, Taylor G, Petch M, Schofield PM. Effect of transcutaneous electrical nerve stimulation on coronary blood flow. Circulation. 1994;89:694–702[Abstract/Free Full Text]
  53. Sanderson JE, Woo KS, Chung HK, Chan WM, Tse LK, White HD. The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X. Coronary Artery Dis. 1996;7:547–552[Web of Science][Medline]
  54. Eliasson T, Albertson P, Hardhammar P, Emmanuelson H, Augustinsson LE, Mannheimer Cl. Spinal cord stimulation in angina pectoris with normal coronary angiograms. Coronary Artery Dis. 1993;4:819–827[Web of Science][Medline]
  55. Rosano GM, Collins P, Kaski JC, Lindsay DC, Sarrel PM, Poole-Wilson A. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J. 1995;16:610–614[Abstract/Free Full Text]
  56. Rees MC, Barlow DH. Absence of sustained reflex vasoconstriction in women with menopausal flushes. Hum Reprod. 1988;3:823–825[Abstract/Free Full Text]
  57. Sarrel PM, Lindsay D, Rosano GM, Poole-Wilson A. Angina and normal coronary arteries in women: gynecologic findings. Am J Obstet Gynecol. 1992;167:467–472[Web of Science][Medline]
  58. Roque M, Heras M, Roig E. Short-term effect of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal coronary angiograms. J Am Coll Cardiol. 1998;31:139–143[Abstract/Free Full Text]
  59. Albertsson PA, Emanuelson H, Milson I. Beneficial effect of treatment with transdermal estradiol-17B on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol. 1996;54:13–20[CrossRef][Web of Science][Medline]
  60. Rosano GM, Peters NS, Lefroy D. 17 B-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol. 1996;28:1500–1505[Abstract]
  61. Potts SG, Bass C. Chest pain and normal coronary arteries: psychological aspects. Kaski JC. Angina pectoris and normal coronary arteries: syndrome X. : Kluwer Academic Publishers; 1999. p. 13–32
  62. Klimes I, Mayou RA, Pearse MJ, Coles L, Fagg JR. Psychological treatment for atypical non-cardiac chest pain: a controlled evaluation. Psychol Med. 1990;20:605–611[Web of Science][Medline]
  63. Mayou RA, Bryant BM, Sanders D, Bass C, Klimes I, Forfar C. A controlled trial of cognitive behavioural therapy for non-cardiac chest pain. Psychol Med. 1997;27:1021–1031[CrossRef][Web of Science][Medline]
  64. Van Peski-Oosterbaan AS, Spinhoven P, Van Rood Y, Van der Does JW, Bruschke AV, Rooijmans HG. Cognitive behavioural therapy for non-cardiac chest pain: a randomized trial. Am J Med. 1999;106:424–429[CrossRef][Web of Science][Medline]
  65. Potts SG, Lewin R, Fox KAA, Johnstone EC, Cay EL. Group psychological treatment for chest pain with normal coronary arteries: a controlled trial. QJM. 1999;92:81–86[Abstract/Free Full Text]
  66. Chambers J. Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience. Int J Cardiol. 1998;65:51–55[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381.
[Full Text] [PDF]

Home page
 CirculationHome page
J. C. Kaski
Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X)
Circulation, February 10, 2004; 109(5): 568 - 572.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Arroyo-Espliguero, N. Mollichelli, P. Avanzas, E. Zouridakis, V. R Newey, D. K Nassiri, and J. C. Kaski
Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X
Eur. Heart J., November 2, 2003; 24(22): 2006 - 2011.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Mohri, H. Shimokawa, Y. Hirakawa, A. Masumoto, and A. Takeshita
Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm
J. Am. Coll. Cardiol., January 1, 2003; 41(1): 15 - 19.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Valenzuela Garcia, L. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaski, J. C.
Right arrow Articles by Valenzuela Garcia, L. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?